Search for: "Eli Lilly " Results 1421 - 1440 of 2,131
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Jul 2010, 12:06 am by Kelly
(Patent Docs) Zometa (Zoledronic acid) – US: Teva and Novartis settle patent dispute over Zometa (Patent Docs) Zyprexa (Olanzapine) – Canada: Patent Act contains no reference to invalid selection patents: Eli Lilly v Novopharm (Patent Baristas) [read post]
21 Jul 2010, 4:33 am by Maxwell Kennerly
The Los Angeles Times featured a story about the legal saga that has enveloped the Christian bestseller The Shack: "The Shack," William Paul Young's novel about a man rediscovering lost faith after the murder of his 5-year-old daughter, started out as a manuscript no one would touch. [read post]
20 Jul 2010, 12:58 pm by mcarzima@imediainc.com
Wetta also blew the whistle on Eli Lilly, while he was employed as a sales representative for that company, for its similar illegal marketing of antipsychotics. [read post]
8 Jul 2010, 1:11 pm by Glenn Reynolds
“The largest such robbery, which happened last March, featured a matinee-worthy heist plan involving a team of thieves rappelling into an Eli Lilly warehouse. [read post]
7 Jul 2010, 5:14 am
(Patent Docs) (Holman's Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs)   Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market generic (Patent Docs)… [read post]
7 Jul 2010, 5:00 am by Todd Penner
Marram also sits on the Board of The New York Times Company and Eli Lilly and Company. [read post]
7 Jul 2010, 3:28 am by Andrew Lavoott Bluestone
Since the issue was actually and necessarily decided in the arbitration, in which CISEF had a full and fair opportunity to litigate the issue, CISEF and the other plaintiffs, who are admittedly in privity with it, are precluded from relitigating it herein (see Kaufman v Eli Lilly & Co., 65 NY2d 449, 455 [1985]; Active Media Servs., Inc. v Grant Prideco, Inc., 35 AD3d 165 [2006]). [read post]
6 Jul 2010, 6:03 pm by Duncan
(Patent Docs) (Holman’s Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs)   Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market generic (Patent Docs)… [read post]
2 Jul 2010, 5:00 pm by Bexis
Eli Lilly & Co., 113 F.3d 1426, 1429 (6th Cir. 1997) ("A federal court in a diversity case is not free to engraft onto state rules exceptions or modifications which may commend themselves to the federal court, but which have not commended themselves to the State in which the federal court sits") (refusing to adopt [read post]
1 Jul 2010, 1:32 pm by Richard Renner
Grassley letters are available in the continuation of this blog entryBelow are links to the letters sent by Grassley to: Abbott Laboratories Amgen AstraZeneca Pharmaceuticals Boehringer Bristol-Myers Squibb Company Eisai Corporation of America Eli Lilly and Company Forest Laboratories GlaxoSmithKline Hoffman-La Roche Inc. [read post]
1 Jul 2010, 6:30 am by Peter Rost
., AstraZeneca Plc and Eli Lilly & Co., to reveal how they treat whistleblowers who file complaints under the False Claims Act.Grassley, an Iowa Republican, sent letters June 28 that posed eight questions such as how companies notify employees of the law, how they treat whistleblowers and what changes they have made in response to a 2009 law extending anti-retaliation protections. [read post]
1 Jul 2010, 5:20 am by Mark Zamora
Image via WikipediaThe FDA launched probes into possible risks from an Eli Lilly and Co (LLY.N) bloodthinner, a Sanofi-Aventis heart drug and other medicines.The FDA released its quarterly list of early investigations into health problems reported with various drugs on Wednesday.On the list, the agency said it was probing cases of thrombotic thrombocytopenic purpura (TTP) in patients treated with Effient, a blood thinner from Lilly and Daiichi Sankyo. [read post]
17 Jun 2010, 5:00 am by Bexis
Eli Lilly & Co., 696 N.E.2d 187 (Ohio 1998)) and a gun case in New York (Hamilton v. [read post]
16 Jun 2010, 7:43 am
Features of note include "Invalidity for lack of Industrial Application - The Court of Appeal hands down its decision in ELi Lilly & Co. v Human Genome Sciences Inc", by the IPKat's friend and IPSoc founder Charlotte Weekes (now with Pinsent Masons).The new UK coalition government is publishing an emergency budget next Tuesday, 22 June. [read post]